Literature DB >> 25036516

Effect of superposition and masking between red blood cell autoantibodies and alloantibodies.

Y Yu1, D Q Wang2.   

Abstract

This study aimed to explore the law of superposition and masking between autoantibodies and alloantibodies, and to ensure the detection of alloantibodies and to improve the safety of warm autoimmune hemolytic anemia patients. Eight kinds of commercial IgG red blood cell antibody reagents were serially diluted, and 3 kinds of antibodies at dilutions showing a continuous gradual decline in agglutination strength with the corresponding antigen red blood cells were treated as the target antibodies. Anti-D and anti-M were treated as simulated autoantibodies, and anti-Fya was treated as a simulated alloantibody. Four concentrations, 4+, 3+, 2+ and 1+, of autoantibodies and three concentrations, 3+, 2+ and 1+, of alloantibodies were combined, and 12 kinds of hybrid antibodies were detected and evaluated by the anti-human globulin micro-column gel assay. When the simulated strong autoantibody (4+) was used, the alloantibodies (3+, 2+, 1+) had no effect on the final agglutination strength; when the strength of agglutination produced by the simulated autoantibody was less than 4+, and at the same time there were alloantibodies (3+, 2+, 1+), the differences in agglutination strength with a panel of RBCs could be clearly observed. Strong autoantibodies (4+) can exert a masking effect, leading to alloantibodies being undetected; autoantibodies less than 4+, will produce the superimposed effect with alloantibodies, resulting in differences in agglutination strength.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25036516     DOI: 10.4238/2014.June.18.9

Source DB:  PubMed          Journal:  Genet Mol Res        ISSN: 1676-5680


  1 in total

1.  Red blood cell alloimmunization among hospitalized patients: transfusion reactions and low alloantibody identification rate.

Authors:  Lívia Lara Pessoni; Marcos Antônio Ferreira; Julles Cristiane Rodrigues da Silva; Keila Correia de Alcântara
Journal:  Hematol Transfus Cell Ther       Date:  2018-05-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.